Kenvue Inc. (New York Stock Exchange:KVUE)
| Market Cap | 34.08B-5.9% |
| Revenue (ttm) | 15.41B+1.8% |
| Net Income | 1.66B+16.9% |
| EPS | 0.87+17.6% |
| Shares Out | 1.92B |
| PE Ratio | 20.40 |
| Forward PE | 14.22 |
| Dividend | $0.83(4.69%) |
| Ex-Dividend Date | Aug 12, 2026 |
| Volume | 22,520,410 |
| Open | 18.14 |
| Previous Close | 18.39 |
| Day's Range | 17.67 - 18.23 |
| 52-Week Range | 14.02 - 20.13 |
| Beta | 0.43 |
| Analysts | Hold |
| Price Target | 19.50(+9.86%) |
| Earnings Date | Nov 2, 2026 |
About KVUE
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
$KVUE stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of KVUE by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Kevin HernHouse / R | Sale$1.00K – $15.00K | Aug 5, 2026 |
| Kevin HernHouse / R | Sale$1.00K – $15.00K | Aug 4, 2026 |
| Gilbert CisnerosHouse / D | Sale$1.00K – $15.00K | Jul 17, 2026 |
| Kevin HernHouse / R | Sale$15.00K – $50.00K | Mar 17, 2026 |
| Kevin HernHouse / R | Sale$15.00K – $50.00K | Mar 16, 2026 |
| Sheldon WhitehouseSenate / D | Sale$1.00K – $15.00K | Aug 28, 2025 |
| Sheldon WhitehouseSenate / D | Sale$1.00K – $15.00K | Nov 18, 2024 |
| Sheldon WhitehouseSenate / D | Purchase$1.00K – $15.00K | Sep 20, 2023 |
Recently reported changes in KVUE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by KVUE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
KVUE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
KVUE Revenue by Segment or Geography
Source: SEC EDGAR (10-Q/10-K)
U.S. Patents
New KVUE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to KVUE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in KVUE
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.18B |
| VOOVanguard S&P 500 ETF | $969.80M |
| VOVanguard Morningstar Mid-Cap ETF | $799.48M |
| IVViShares Core S&P 500 ETF | $475.77M |
| SPYState Street SPDR S&P 500 ETF | $433.94M |
| VTVVanguard Morningstar Value ETF | $351.83M |
Estimated from each fund’s disclosed top holdings × AUM
KVUE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from KVUE’s recent data — informational, not investment advice